News from Eli Lilly

Eli Lilly stock soars after late-stage weight-loss trial meets goals

Eli Lilly and Company (LLY): Among Billionaire Ken Fisher’s Top Growth Stock Picks

Eli Lilly Alzheimer’s drug Kisunla fails to get EU backing

J&J boosts investments in US to more than $55 billion amid looming tariff threats

Three of the best stocks to buy right now: Eli Lilly, Novo Nordisk, and more

Where Will Eli Lilly Be in 5 Years?

Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access

Eli Lilly reports mixed earnings, increases 2025 guidance

Eli Lilly stock rises slightly after drug giant reports adjusted earnings of $5.32 per share on $13.53 billion in sales

Lilly needs a plan to spur weight-loss drug sales, investors say

Eli Lilly lowers guidance for December quarter amid slower-than-expected sales for weight loss drugs

Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand

Eli Lilly forecasts weaker Q4 sales of weight-loss drug, Mounjaro than expected